Gene · 2235
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics reveals subtype-specific molecular profiles in Nrf2-deficient macrophages from murine atherosclerotic aortas. | Front Immunol | 2023 | 37965327 | PubTator, text mining | PubMed |
| Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy. | Cancers (Basel) | 2023 | 37958332 | PubTator, text mining | PubMed |
| Congenital erythropoietic porphyria presenting with recurrent epistaxis: a case report. | J Med Case Rep | 2023 | 37957719 | PubTator, text mining | PubMed |
| Differences in Leukocyte Transcriptomes of Morbidly Obese Patients With High Output Heart Failure: A Pilot Study. | Int J Heart Fail | 2023 | 37937202 | PubTator, text mining | PubMed |
| Peptide Conjugates of a 2'-O-Methoxyethyl Phosphorothioate Splice-Switching Oligonucleotide Show Increased Entrapment in Endosomes. | ACS Omega | 2023 | 37929104 | PubTator, text mining | PubMed |
| Coordination chemistry of mitochondrial copper metalloenzymes: exploring implications for copper dyshomeostasis in cell death. | BMB Rep | 2023 | 37915136 | PubTator, text mining | PubMed |
| Is a 4 J/cm2 PpIX-Weighted Simulated Daylight (SDL-PDT) Dose Still Efficient for Photodynamic Therapy of Actinic Keratosis? | Pharmaceuticals (Basel) | 2023 | 37895925 | PubTator, text mining | PubMed |
| STS and PUDP Deletion Identified by Targeted Panel Sequencing with CNV Analysis in X-Linked Ichthyosis: A Case Report and Literature Review. | Genes (Basel) | 2023 | 37895274 | PubTator, text mining | PubMed |
| Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura. | Nat Genet | 2023 | 37884687 | PubTator, text mining | PubMed |
| Harnessing large language models (LLMs) for candidate gene prioritization and selection. | J Transl Med | 2023 | 37845713 | PubTator, text mining | PubMed |
| Photodynamic therapy and associated targeting methods for treatment of brain cancer. | Front Pharmacol | 2023 | 37841921 | PubTator, text mining | PubMed |
| Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis. | Int J Mol Sci | 2023 | 37834119 | PubTator, text mining | PubMed |
| NRF2, a Superstar of Ferroptosis. | Antioxidants (Basel) | 2023 | 37760042 | PubTator, text mining | PubMed |
| AI-driven pan-proteome analyses reveal insights into the biohydrometallurgical properties of Acidithiobacillia. | Front Microbiol | 2023 | 37744906 | PubTator, text mining | PubMed |
| Iron insertion into coproporphyrin III-ferrochelatase complex: Evidence for an intermediate distorted catalytic species. | Protein Sci | 2023 | 37743577 | PubTator, text mining | PubMed |
| Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases. | Cell Death Dis | 2023 | 37739961 | PubTator, text mining | PubMed |
Intraoperative Fluorophores: An Update on 5-Aminolevulinic Acid and Sodium Fluorescein in Resection of Tumors of the Central Nervous System and Metastatic Lesions-A Systematic Review and Meta-Analysis. | Tomography | 2023 | 37736977 | PubTator, text mining | PubMed |
| Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis. | J Clin Invest | 2023 | 37733441 | PubTator, text mining | PubMed |
| Hepatic farnesoid X receptor is necessary to facilitate ductular reaction and expression of heme biosynthetic genes. | Hepatol Commun | 2023 | 37695073 | PubTator, text mining | PubMed |
| The Regulation of Ferroptosis by Noncoding RNAs. | Int J Mol Sci | 2023 | 37686142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2235/papers?page=7